BOSTON, MA, December 3, 2024 – Relu is proud to announce that it has been named to CB Insights 2024 Digital Health 50 — a list of the world's 50 most promising private digital health companies, selected based on a combination of data signals and proprietary scoring.
“The 2024 Digital Health 50 cohort highlights high-momentum companies driving meaningful change across healthcare,” said Amrit Panjabi, Intelligence Analyst at CB Insights. “This year’s winners are at the forefront of bringing anAI-driven infrastructure to healthcare, transforming diagnostics, and bringing condition-specific care platforms to patients and providers. These companies are accelerating the transformation of healthcare delivery, streamlining workflows, and advancing patient outcomes globally.”
“We’re grateful for this recognition,”said Holger Willems, CEO and co-founder, Relu. “It only strengthens our belief that AI is going to play a very big role in dental treatments, and we’re so fortunate to be on the forefront of this technology wave.”
The announcement caps an accomplishment-packed year for Relu. In September 2024, the company announced that it had secured FDA 510(k) clearance and CE marking for Relu® Creator,its revolutionary dental software. In October 2024, Relu opened a new office in Harvard Square, Boston to support Relu’s rapidly-growing U.S. client base. Relu was one of 12 finalist companies to present in the Technology Showcase and Innovation Expo at ADA Forsyth dentech 2024, the world’s leading oral health innovation investment forum. With the inclusion in CB Insights 2024 Digital Health 50, 2024 is a landmark year.
A bigger vision
“With Relu® Engine, we’ve automated and enhanced dental treatment planning, saving dental practitioners and labs a lot of time and providing them with much greater visibility on patients’ teeth, including roots and bone,” said Willems. “Now, we’re expanding our vision to make implant dentistry a lot more accessible. 178 million Americans alone are missing at least one tooth, and 40 million are missing all of their teeth (American College of Prosthodontists). We want to make it easier for patients to get dental implant procedures, even when they may not have access to a specialist.”
CB Insights’ criteria in determining the 2024 Digital Health 50
From a pool of 10,000+ digital health startups, CBInsights analyzed companies using its proprietary metrics — Commercial Maturity and Mosaic scores — along with additional data on partnerships,funding, patents, leadership, and headcount. CB Insights supplemented this analysis with direct company submissions via Analyst Briefings.
Quick facts on the 2024 Digital Health 50:
● $3.5Bin equity funding raised over time, including more than $1.5B in 2024 so far(as of 11/14/2024)
● 72%of winners are building AI products, addressing everything from drug development to treatment selection to clinical documentation
● 56%of winners are early-stage companies (seed or Series A)
● Winners from 9 countries across the globe: the United States, Germany, Canada, Israel,South Korea, the United Kingdom, New Zealand, Belgium, and France
● 200+business relationships since 2022, including with industry leaders like Nvidia and Kaiser Permanente
AboutRelu
Relu was founded in 2019 with the dream of making dental treatments safer and faster. They plug in advanced computer vision and artificial intelligence to automate manual workflows. Relu® Engine and Relu® Creator are used by dental lab and software partners for more than thousands of orthodontic and implant treatments every day. Relu is headquartered in Leuven, Belgium, with an office in Boston, MA, USA. Learn more at relu.eu.
About CB Insights
CB Insights is an AIsuper analyst for market intelligence. It delivers instant insights that help you bet on the right markets, track competitors, and source the right companies. This AI super analyst is powerful because it is built on the validated database of companies and markets that CB Insights is famous for. To learn more, please visit www.cbinsights.com.
